Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More
Portfolio Pulse from Lara Goldstein
The Energia Foundation is hosting a psychedelics education event in Dubai, while new research finds a key receptor for treating depression with psychedelics. Creso Pharma (OTC:COPHF) signs an LOI for importing Swiss MDMA and psilocybin therapeutics to Australia. AdvisorShares Psychedelics ETF (NYSE:PSIL) shows a consistent upward trend.
June 13, 2023 | 2:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Creso Pharma signs LOI for importing Swiss MDMA and psilocybin therapeutics to Australia, with detailed commercial aspects expected by August 31.
The LOI with Swiss pharmacy Apotheke Dr. Hysek AG for importing licensed MDMA and psilocybin products into Australia could potentially expand Creso Pharma's market reach and product offerings. This may positively impact the company's stock price in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
AdvisorShares Psychedelics ETF (NYSE:PSIL) shows a consistent upward trend, with the yearly price range set between $4.35 and $1.65.
The consistent upward trend in the opening price of the AdvisorShares Psychedelics ETF (NYSE:PSIL) indicates growing interest in the psychedelics sector. This may positively impact the ETF's price in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80